MEI PHARMA INC (MEIP)

US55279B3015 - Common Stock

3.05  -0.05 (-1.61%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-12-31)
2023
(2023-6-30)
2022
(2022-6-30)
2021
(2021-6-30)
2020
(2020-6-30)
Revenue
72.65M48.82M40.70M34.80M27.76M
Cost Of Goods
N/AN/A0.001.41M2.67M
Gross Profit
N/AN/A40.70M33.39M25.09M
Operating Expenses
56.78M85.58M116.18M93.81M50.78M
Research and Development
25.07M52.45M85.64M69.40M34.07M
Selling, General, and Administrative Expenses
31.70M33.13M30.54M24.41M16.72M
Operating Income
15.88M-36.76M-75.48M-60.42M-25.70M
Interest Income/Expense
3.98M3.35M280.00K510.00K1.40M
Other Income/Expense
-12.00K1.58M20.75M18.61M-22.87M
Income Before Taxes
19.84M-31.84M-54.45M-41.31M-47.17M
Income Tax
N/AN/A0.0010.00K0.00
Net Income
19.84M-31.84M-54.45M-41.31M-47.17M
EBITDA
16.25M-36.37M-75.15M-60.13M-25.59M
 
Per Share Data
EPS Diluted Total Ops
2.97-4.78-8.75-7.34-10.36
Non GAAP EPS
2.97-4.63-4.91-0.45-0.53
 
Statistics
Gross Profit Margin
N/AN/A100.00%95.95%90.38%
Profit Margin
27.30%-65.22%-133.78%-118.71%-169.92%
Operating Profit Margin
21.86%-75.30%-185.45%-173.62%-92.58%

All data in USD

Charts